|Comprehensive characterization of cancer driver genes and mutations|
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
|Induction of CD8+ T-cell responses against novel glioma–associated antigen peptides and clinical activity by vaccinations with α-type 1 polarized dendritic cells and …|
H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ...
Journal of clinical oncology 29 (3), 330, 2011
|Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment|
S Müller, G Kohanbash, SJ Liu, B Alvarado, D Carrera, A Bhaduri, ...
Genome biology 18, 1-14, 2017
|COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor CellsCOX-2 Blockade and Gliomagenesis|
M Fujita, G Kohanbash, W Fellows-Mayle, RL Hamilton, Y Komohara, ...
Cancer research 71 (7), 2664-2674, 2011
|Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas|
G Kohanbash, DA Carrera, S Shrivastav, BJ Ahn, N Jahan, T Mazor, ...
The Journal of clinical investigation 127 (4), 1425-1437, 2017
|Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1|
R Ueda, G Kohanbash, K Sasaki, M Fujita, X Zhu, ER Kastenhuber, ...
Proceedings of the National Academy of Sciences 106 (26), 10746-10751, 2009
|Immunotherapeutic approaches for glioma|
H Okada, G Kohanbash, X Zhu, ER Kastenhuber, A Hoji, R Ueda, M Fujita
Critical Reviews™ in Immunology 29 (1), 2009
|GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-αIL-4Rα+ Suppressive Myeloid Cells in Gliomas|
G Kohanbash, K McKaveney, M Sakaki, R Ueda, AH Mintz, N Amankulor, ...
Cancer research 73 (21), 6413-6423, 2013
|The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of VariationA Draft Single-cell Atlas of Human Glioma|
L Wang, H Babikir, S Müller, G Yagnik, K Shamardani, F Catalan, ...
Cancer discovery 9 (12), 1708-1719, 2019
|Novel and shared neoantigen derived from histone 3 variant H3. 3K27M mutation for glioma T cell therapy|
ZS Chheda, G Kohanbash, K Okada, N Jahan, J Sidney, M Pecoraro, ...
Journal of Experimental Medicine 215 (1), 141-157, 2018
|MicroRNAs in immune regulation—opportunities for cancer immunotherapy|
H Okada, G Kohanbash, MT Lotze
The international journal of biochemistry & cell biology 42 (8), 1256-1261, 2010
|Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide VaccinesTGF-β Blockade …|
R Ueda, M Fujita, X Zhu, K Sasaki, ER Kastenhuber, G Kohanbash, ...
Clinical Cancer Research 15 (21), 6551-6559, 2009
|IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression|
X Zhang, A Rao, P Sette, C Deibert, A Pomerantz, WJ Kim, G Kohanbash, ...
Neuro-oncology 18 (10), 1402-1412, 2016
|MicroRNAs and STAT interplay|
G Kohanbash, H Okada
Seminars in cancer biology 22 (1), 70-75, 2012
|Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells—significant roles of CXCL10|
M Fujita, X Zhu, R Ueda, K Sasaki, G Kohanbash, ER Kastenhuber, ...
Cancer research 69 (4), 1587-1595, 2009
|Single‐cell sequencing maps gene expression to mutational phylogenies in PDGF‐and EGF‐driven gliomas|
S Müller, SJ Liu, E Di Lullo, M Malatesta, AA Pollen, TJ Nowakowski, ...
Molecular systems biology 12 (11), 889, 2016
|Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas|
H Okada, KL Low, G Kohanbash, HA McDonald, RL Hamilton, IF Pollack
Journal of neuro-oncology 88, 245-250, 2008
|Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC|
H Okada, LH Butterfield, RL Hamilton, A Hoji, M Sakaki, BJ Ahn, ...
Clinical cancer research 21 (2), 286-294, 2015
|Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners|
X Zhu, BA Fallert-Junecko, M Fujita, R Ueda, G Kohanbash, ...
Cancer Immunology, Immunotherapy 59, 1401-1409, 2010
|Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma|
SJ Han, G Reis, G Kohanbash, S Shrivastav, ST Magill, AM Molinaro, ...
Journal of neuro-oncology 130, 543-552, 2016